Predicting who is at high risk for a heart attack or death may be as simple as obtaining a person's coronary artery calcium ...

A prescription medication that has been available in the U.S. since 1992 might have another significant benefit.

Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed ...

Subset analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis in difficult-to-treat MASH patientsBoth artificial ...

Several studies have shown that niacin can significantly reduce the level of low-density lipoprotein cholesterol (bad cholesterol ... event risks and that it may increase the risk of all-cause ...

UK are still fighting against the pandemic-causing disease and the rise of new variants means many more are still to be ...

The surprising things your heart doctor really thinks about your weight, your red wine habit, and more. The post 25 ...

In this new research, scientists analyzed data from electronic health records covering over 900,000 patients. The study ...

KEY BUSINESS HIGHLIGHTSPhase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease expected to ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense and respond to danger. However, for people with risks for heart disease, ...

There’s a local program called the Gene Health Project, and the idea is to learn any bad genetic news about yourself but learn it so early – that it’s actually ...